FindTrial
Sign In

Fu's Subcutaneous Needling Improves Muscle Function in Cervical Radiculopathy: A Randomized Trial

The Efficacy of Acupuncture Exercise Therapy for Spinal Degenerative Diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001613
Enrollment
Unknown
Registered
2025-08-28
Start date
2023-09-28
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Degenerative spinal disorders (cervical spondylotic radiculopathy and lumbar disc herniation)

Interventions

Intervention Group :The intervention group received Fu's subcutaneous needling (FSN) therapy targeting specific muscles-namely, the upper trapezius and levator scapulae for cervical spondylotic radic
Control Group:The control group received conventional pharmacological treatment, including celecoxib capsules (100 mg, orally, twice daily), mecobalamin tablets (500 µg, orally, three times daily), an

Sponsors

Guangdong Second Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: Patients must present with clinically significant neck/shoulder or low back/leg pain (VAS =4 for =2 months) accompanied by radicular symptoms, demonstrate positive nerve root tension tests (Spurling's test/brachial plexus traction test for cervical cases or SLR <60°/femoral nerve stretch test for lumbar cases) with documented abnormal stiffness in target muscles (upper trapezius/levator scapulae for cervical or quadr

Exclusion criteria

Exclusion criteria: Exclusion Criteria: Patients aged 75 years; those with spinal surgery history or trauma within 3 months, congenital skeletal disorders (e.g., ankylosing spondylitis), spinal infections/tumors; confounding conditions including frozen shoulder, joint ligament injuries, peripheral neuropathy, or spinal interventions within 6 months; special populations (pregnant/lactating women or individuals allergic to study medications like celecoxib/methylcobalamin); and cases with psychiatric/cognitive impairments affecting evaluations.

Design outcomes

Primary

MeasureTime frame
NPQ Score (Northwick Park Questionnaire Score);VAS Score (Visual Analogue Scale Score);Oswestry Disability Index;JOA Score (Japanese Orthopaedic Association Score);Muscle Elasticity;Muscle Stiffness;Muscle Tone;—

Secondary

MeasureTime frame
Modified MacNab Classification Criteria;—

Countries

CHINA

Contacts

Public ContactLong chen

Guangdong Second Chinese Medicine Hospital

5256468807@qq.com19303029737

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026